Sign In
Buy LH
$276.81
-0.82 (-0.295%)
At Close: Jul 10, 2026
Why Labcorp Holdings (LH) is a Top Value Stock for the Long-Term
10:40am, Monday, 13'th Jul 2026
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Labcorp Declares Quarterly Dividend
05:05pm, Thursday, 09'th Jul 2026
BURLINGTON, N.C., July 9, 2026 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has de
Here's Why Labcorp Holdings (LH) is a Strong Momentum Stock
10:51am, Tuesday, 07'th Jul 2026
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
LH or CRL: Which Is the Better Value Stock Right Now?
12:40pm, Wednesday, 01'st Jul 2026
Investors with an interest in Medical Services stocks have likely encountered both Labcorp Holdings (LH) and Charles River Laboratories (CRL). But which of these two companies is the best option for t
Labcorp to Announce Second Quarter 2026 Financial Results on July 30, 2026
04:15pm, Tuesday, 30'th Jun 2026
BURLINGTON, N.C., June 30, 2026 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the second
Is it the Right Time to Add Labcorp Stock to Your Portfolio?
12:56pm, Thursday, 25'th Jun 2026
LH expands specialty testing, acquisitions and AI initiatives to drive growth, but macro pressures and currency headwinds could weigh on results.
Here's Why Labcorp Holdings (LH) is a Strong Value Stock
10:41am, Thursday, 25'th Jun 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
First FDA-approved, at-home screening test that uses RNA technology to detect biomarkers associated with colorectal cancer and advanced adenomas Designed to reduce common barriers to at-home screening
LH vs. CRL: Which Stock Is the Better Value Option?
12:41pm, Monday, 15'th Jun 2026
Investors looking for stocks in the Medical Services sector might want to consider either Labcorp Holdings (LH) or Charles River Laboratories (CRL). But which of these two stocks offers value investor
Why Labcorp Holdings (LH) is a Top Momentum Stock for the Long-Term
10:51am, Monday, 08'th Jun 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why Labcorp Holdings (LH) is a Strong Value Stock
10:40am, Friday, 05'th Jun 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Labcorp Holdings Inc. (LH) Presents at Jefferies Global Healthcare Conference 2026 Transcript
02:22pm, Wednesday, 03'rd Jun 2026
Labcorp Holdings Inc. (LH) Presents at Jefferies Global Healthcare Conference 2026 Transcript
LH Expands Genetic Testing in CRC Through New Collab: Stock to Gain?
10:16am, Monday, 01'st Jun 2026
Labcorp joins a national CRC trial as exclusive genetic testing provider, expanding Invitae-based testing and supporting cancer research.
Labcorp Supports Multi-Institution Trial to Expand Genetic Testing in Colorectal Cancer
08:00am, Friday, 29'th May 2026
Labcorp Supports Multi-Institution Trial to Expand Genetic Testing in Colorectal Cancer PR Newswire BURLINGTON,
Labcorp Supports Multi-Institution Trial to Expand Genetic Testing in Colorectal Cancer
07:00am, Friday, 29'th May 2026
Collaborative trial with Alliance for Clinical Trials in Oncology will evaluate new approaches to increase germline genetic testing among at-risk family members Research will also assess the clinical
